Ironwood Pharmaceuticals (IRWD) Earnings
|
Expand Research on IRWD
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +21.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +14.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | $0.19 | N/A | N/A | $86.11M | = | N/A | N/A | ||
| 2/18/26 |
Q425 | N/A | $0.02 | N/A | N/A | $62.43M | = | N/A | N/A | ||
| 2/17/26 |
Q425 | N/A | $0.02 | N/A | N/A | $62.43M | = | N/A | N/A | ||
| 2/16/26 |
Q425 | N/A | $0.02 | N/A | N/A | $62.43M | = | N/A | N/A | ||
| 2/12/26 |
Q425 | N/A | $0.02 | N/A | N/A | $62.43M | = | N/A | N/A | ||
| 2/25/26 | Q425 | -$0.01 | $0.02 | -$0.03 | $47.71M | $62.43M | = |  | | Details | |
| 11/10/25 | Q325 | $0.24 | $0.11 | +$0.13 | $122.06M | $72.9M | = | | | Details | |
| 11/7/25 |
Q325 | N/A | $0.11 | N/A | N/A | $72.9M | = | N/A | N/A |
